Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Edesa Biotech, Inc. (EDSA) had Income from Continuous Operations of $-1.59M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.59M |
|
-- |
|
-- |
|
$1.64M |
|
$-1.64M |
|
$0.05M |
|
$-1.59M |
|
$-1.59M |
|
$-1.59M |
|
|
Income from Continuous Operations |
$-1.59M |
$-1.59M |
|
$-1.59M |
|
$-1.64M |
|
$-1.61M |
|
5.31M |
|
5.31M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$14.39M |
|
-- |
|
$2.07M |
|
$16.45M |
|
$0.91M |
|
-- |
|
-- |
|
$0.91M |
|
$6.35M |
|
$13.51M |
|
$15.54M |
|
7.02M |
|
| Cash Flow Statement Financials | |
$-3.90M |
|
-- |
|
$16.84M |
|
$1.04M |
|
$13.90M |
|
$12.86M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.03% |
|
-11.77% |
|
-9.67% |
|
-10.23% |
|
$2.21 |
|
$-0.74 |
|
$-0.74 |
|